Health
Clinical trial to test existing antibiotic for treating serious S. aureus infections begins – News-Medical.Net
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun.
A clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia has begun. The trial will enroll 200 adults hospitalized with complicated S. aureus infection at approximately 20 trial sites around the United States. The trial is being sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
S. aureus is a leading cause of antibiotic-resistant infection….
-
General23 hours agoVideo allegedly showing man trying to catch freshwater crocodile prompts investigation
-
General23 hours agoBrotherly bond key to Birdsville Races epic journey
-
General18 hours agoGiorgio Armani farewelled by large crowds of mourners in Milan
-
Noosa News13 hours agoBruce and Denise Morcombe discuss Daniel’s Law